UBS Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $151M | Buy |
564,529
+68,994
| +14% | +$18.7M | 0.02% | 768 |
|
|
2025
Q4 | $124M | Buy |
495,535
+10,506
| +2% | +$2.79M | 0.02% | 860 |
|
|
2025
Q3 | $139M | Sell |
485,029
-12,401
| -2% | -$3.32M | 0.02% | 798 |
|
|
2025
Q2 | $131M | Buy |
497,430
+55,790
| +13% | +$13.6M | 0.02% | 779 |
|
|
2025
Q1 | $103M | Buy |
441,640
+53,918
| +14% | +$13.1M | 0.02% | 912 |
|
|
2024
Q4 | $88.9M | Buy |
387,722
+21,398
| +6% | +$4.91M | 0.02% | 996 |
|
|
2024
Q3 | $81.9M | Sell |
366,324
-17,675
| -5% | -$3.88M | 0.02% | 842 |
|
|
2024
Q2 | $78.1M | Sell |
383,999
-86,124
| -18% | -$17.5M | 0.02% | 765 |
|
|
2024
Q1 | $103M | Buy |
470,123
+66,298
| +16% | +$14.6M | 0.03% | 633 |
|
|
2023
Q4 | $91.8M | Sell |
403,825
-28,301
| -7% | -$5.95M | 0.03% | 614 |
|
|
2023
Q3 | $86.9M | Sell |
432,126
-59,376
| -12% | -$12.5M | 0.03% | 554 |
|
|
2023
Q2 | $102M | Buy |
491,502
+11,928
| +2% | +$2.31M | 0.03% | 490 |
|
|
2023
Q1 | $94.5M | Buy |
479,574
+82,430
| +21% | +$17M | 0.03% | 479 |
|
|
2022
Q4 | $80.3M | Buy |
397,144
+48,283
| +14% | +$9.44M | 0.03% | 579 |
|
|
2022
Q3 | $61.4M | Sell |
348,861
-26,147
| -7% | -$5.35M | 0.03% | 601 |
|
|
2022
Q2 | $75.5M | Sell |
375,008
-32,422
| -8% | -$6.91M | 0.03% | 543 |
|
|
2022
Q1 | $92.3M | Sell |
407,430
-58,388
| -13% | -$13.7M | 0.03% | 548 |
|
|
2021
Q4 | $126M | Buy |
465,818
+16,505
| +4% | +$4.09M | 0.04% | 509 |
|
|
2021
Q3 | $109M | Buy |
449,313
+24,448
| +6% | +$6.16M | 0.03% | 505 |
|
|
2021
Q2 | $101M | Buy |
424,865
+373
| +0.1% | +$85K | 0.03% | 517 |
|
|
2021
Q1 | $93M | Sell |
424,492
-6,074
| -1% | -$1.22M | 0.03% | 547 |
|
|
2020
Q4 | $75.3M | Buy |
430,566
+34,188
| +9% | +$5.91M | 0.03% | 585 |
|
|
2020
Q3 | $64.1M | Sell |
396,378
-1,810
| -0.5% | -$287K | 0.02% | 552 |
|
|
2020
Q2 | $56.8M | Buy |
398,188
+5,826
| +1% | +$806K | 0.02% | 550 |
|
|
2020
Q1 | $42.6M | Sell |
392,362
-77,370
| -16% | -$11.1M | 0.02% | 611 |
|
|
2019
Q4 | $68.3M | Buy |
469,732
+37,605
| +9% | +$5.43M | 0.02% | 597 |
|
|
2019
Q3 | $62.4M | Buy |
432,127
+51,563
| +14% | +$7.52M | 0.02% | 577 |
|
|
2019
Q2 | $56.5M | Buy |
380,564
+166,261
| +78% | +$23.2M | 0.02% | 617 |
|
|
2019
Q1 | $28.2M | Buy |
214,303
+23,541
| +12% | +$2.9M | 0.01% | 944 |
|
|
2018
Q4 | $20.7M | Sell |
190,762
-53,673
| -22% | -$7.19M | 0.01% | 1057 |
|
|
2018
Q3 | $36.5M | Buy |
244,435
+49,903
| +26% | +$7.59M | 0.01% | 832 |
|
|
2018
Q2 | $30M | Buy |
194,532
+21,648
| +13% | +$3.27M | 0.01% | 928 |
|
|
2018
Q1 | $24M | Sell |
172,884
-11,491
| -6% | -$1.69M | 0.01% | 1026 |
|
|
2017
Q4 | $25.3M | Buy |
184,375
+44,849
| +32% | +$5.93M | 0.01% | 1041 |
|
|
2017
Q3 | $18.1M | Buy |
139,526
+50,424
| +57% | +$6.73M | 0.01% | 1162 |
|
|
2017
Q2 | $11.8M | Sell |
89,102
-16,580
| -16% | -$2.03M | 0.01% | 1408 |
|
|
2017
Q1 | $13M | Buy |
105,682
+16,133
| +18% | +$1.91M | 0.01% | 1296 |
|
|
2016
Q4 | $9.88M | Sell |
89,549
-14,389
| -14% | -$1.6M | 0.01% | 1506 |
|
|
2016
Q3 | $12.3M | Sell |
103,938
-16,333
| -14% | -$1.92M | 0.01% | 1275 |
|
|
2016
Q2 | $13.5M | Sell |
120,271
-752,599
| -86% | -$81M | 0.01% | 1191 |
|
|
2016
Q1 | $87.8M | Buy |
872,870
+419,799
| +93% | +$40.2M | 0.06% | 303 |
|
|
2015
Q4 | $48.1M | Buy |
453,071
+335,581
| +286% | +$34.6M | 0.03% | 522 |
|
|
2015
Q3 | $10.9M | Buy |
117,490
+26,838
| +30% | +$2.78M | 0.01% | 1306 |
|
|
2015
Q2 | $9.44M | Sell |
90,652
-11,633
| -11% | -$1.21M | 0.01% | 1527 |
|
|
2015
Q1 | $11.1M | Buy |
102,285
+1,291
| +1% | +$133K | 0.01% | 1397 |
|
|
2014
Q4 | $9.36M | Buy |
+100,994
| New | +$8.92M | 0.01% | 1554 |
|
Other funds holding LH
VCM
VPM
UBS Group's LH Position: Q1 2026 in Review
UBS Group increased its Labcorp (LH) stake by 14% in Q1 2026, buying an estimated $18.7M and bringing the position to 564,529 shares worth $151M. The position accounts for 0.02% of the portfolio, ranked #768.
UBS Group first reported a position in LH in Q4 2014 and has held it in 46 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- UBS Group held 564,529 shares of Labcorp worth $151M as of Q1 2026.
- UBS Group bought 68,994 Labcorp shares in Q1 2026, an estimated $18.7M.
- Labcorp made up 0.02% of UBS Group's portfolio in Q1 2026, its #768 holding.
- UBS Group first reported a position in Labcorp in Q4 2014 and has held it in 46 quarters since.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.